1187732-31-5

Basic information

• Product Name: 2-(benzylsulfanyl)-6-methoxybenzaldehyde
• Synonyms: 2-(benzylsulfanyl)-6-methoxybenzaldehyde
• CAS NO: 1187732-31-5
• Molecular Weight: 258.341
• Mol File: 1187732-31-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-(benzylsulfanyl)-6-methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(benzylsulfanyl)-6-methoxybenzaldehyde(1187732-31-5)
• EPA Substance Registry System: 2-(benzylsulfanyl)-6-methoxybenzaldehyde(1187732-31-5)

Safety Data

• Hazardous Substances Data: 1187732-31-5(Hazardous Substances Data)

Upstream product

• 146137-74-8 2-fluoro-6-methoxybenzaldehyde 
• 100-53-8 phenylmethanethiol 

Downstream Products

• 1124250-10-7 4-(1,2-benzisothiazol-4-yloxy)-3-chloroaniline 
• 1124250-06-1 4-(2-chloro-4-nitrophenoxy)-1,2-benzisothiazole 
• 67982-15-4 4-Hydroxy-1,2-benzisothiazol 

Relevant articles and documents

1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS

A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

FUSED HETEROCYCLIC COMPOUND

The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: wherein ring A is an optionally substituted benzene ring;ring B is an optionally substituted benzoisothiazole rin